{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:10:51Z","timestamp":1783955451508,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai \u201c14th Five-Year Plan\u201d Traditional Chinese Medicine Characteristic Specialty Incubation Project","award":["Grant No. ZYTSZK2-7"],"award-info":[{"award-number":["Grant No. ZYTSZK2-7"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No. 82304446"],"award-info":[{"award-number":["Grant No. 82304446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02185-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:23:17Z","timestamp":1779254597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A microfluidic lung cancer-vascular tumor-on-a-chip model for precise evaluation of anti-invasion therapeutics"],"prefix":"10.1007","volume":"26","author":[{"given":"Jinnuo","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoucheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Xuzhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"3","key":"2185_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. 21834. PubMed PMID: 38572751.","journal-title":"CA Cancer J Clin"},{"key":"2185_CR2","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, Cancer statistics. 2025. CA Cancer J Clin. 2025;75(1):10\u201345. Epub 20250116. doi: 10.3322\/caac.21871. PubMed PMID: 39817679; PubMed Central PMCID: PMC11745215.","DOI":"10.3322\/caac.21871"},{"issue":"1","key":"2185_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/cco.0000000000000703","volume":"33","author":"F Wu","year":"2021","unstructured":"Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40\u20136. https:\/\/doi.org\/10.1097\/cco.0000000000000703. Epub 2020\/11\/10.","journal-title":"Curr Opin Oncol"},{"issue":"12","key":"2185_CR4","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","volume":"32","author":"J Remon","year":"2021","unstructured":"Remon J, Soria JC, Peters S. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol. 2021;32(12):1637\u201342. 1994. PubMed PMID: 34481037.","journal-title":"Ann Oncol"},{"issue":"6","key":"2185_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/joim.13445","volume":"291","author":"M Skribek","year":"2022","unstructured":"Skribek M, Rounis K, Tsakonas G, Ekman S. Complications following novel therapies for non-small cell lung cancer. J Intern Med. 2022;291(6):732\u201354. https:\/\/doi.org\/10.1111\/joim.13445. Epub 2022\/01\/16.","journal-title":"J Intern Med"},{"key":"2185_CR6","doi-asserted-by":"publisher","unstructured":"Miao K, Liu W, Xu J, Qian Z, Zhang Q. Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1277243. :1277243. Epub 2023\/11\/30.","DOI":"10.3389\/fimmu.2023.1277243"},{"issue":"5","key":"2185_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5582\/bst.2021.01318","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021;15(5):283\u201398. https:\/\/doi.org\/10.5582\/bst.2021.01318. Epub 2021\/08\/24.","journal-title":"Biosci Trends"},{"key":"2185_CR8","doi-asserted-by":"publisher","first-page":"155131","DOI":"10.1016\/j.phymed.2023.155131","volume":"121","author":"QR Hu","year":"2023","unstructured":"Hu QR, Huang QX, Hong H, Pan Y, Luo T, Li J, et al. Ginsenoside Rh2 and its octyl ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the c-Jun\/COX2\/PGE2 pathway. Phytomedicine. 2023;121:155131. https:\/\/doi.org\/10.1016\/j.phymed.2023.155131. Epub 20231006.","journal-title":"Phytomedicine"},{"issue":"1","key":"2185_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/s0192415x16500014","volume":"44","author":"KK Auyeung","year":"2016","unstructured":"Auyeung KK, Han QB, Ko JK. Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers. Am J Chin Med. 2016;44(1):1\u201322. https:\/\/doi.org\/10.1142\/s0192415x16500014. Epub 2016\/02\/27.","journal-title":"Am J Chin Med"},{"issue":"1","key":"2185_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.intimp.2014.08.027","volume":"23","author":"X Cheng","year":"2014","unstructured":"Cheng X, Gu J, Zhang M, Yuan J, Zhao B, Jiang J, et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-\u03b1-ERK1\/2-NF-\u03baB pathway. Int Immunopharmacol. 2014;23(1):304\u201313. .027. PubMed PMID: 25218161.","journal-title":"Int Immunopharmacol"},{"key":"2185_CR11","doi-asserted-by":"publisher","unstructured":"Yousef M, Vlachogiannis IA, Tsiani E. Effects of Resveratrol against Lung Cancer: In Vitro and. Vivo Stud Nutrients. 2017;9(11). https:\/\/doi.org\/10.3390\/nu9111231. PubMed PMID: 29125563; PubMed Central PMCID: PMC5707703. Epub 2017\/11\/11.","DOI":"10.3390\/nu9111231"},{"issue":"1","key":"2185_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-022-02801-w","volume":"22","author":"P Bouchalova","year":"2022","unstructured":"Bouchalova P, Bouchal P. Current methods for studying metastatic potential of tumor cells. Cancer Cell Int. 2022;22(1):394. Epub 20221209. doi: 10.1186\/s12935-022-02801-w. PubMed PMID: 36494720; PubMed Central PMCID: PMC9733110.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2185_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1073\/pnas.1417115112","volume":"112","author":"JS Jeon","year":"2015","unstructured":"Jeon JS, Bersini S, Gilardi M, Dubini G, Charest JL, Moretti M, et al. Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci U S A. 2015;112(1):214\u20139. https:\/\/doi.org\/10.1073\/pnas.1417115112. Epub 20141218.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2185_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.018","author":"MB Chen","year":"2017","unstructured":"Chen MB, Whisler JA, Fr\u00f6se J, Yu C, Shin Y, Kamm RD. Nat Protoc. 2017;12(5):865\u201380. https:\/\/doi.org\/10.1038\/nprot.2017.018. Epub 20170330. On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics."},{"issue":"35","key":"2185_CR15","doi-asserted-by":"publisher","first-page":"e2300692","DOI":"10.1002\/adma.202300692","volume":"35","author":"JF Gil","year":"2023","unstructured":"Gil JF, Moura CS, Silverio V, Gon\u00e7alves G, Santos HA. Cancer Models on Chip: Paving the Way to Large-Scale Trial Applications. Adv Mater. 2023;35(35):e2300692. https:\/\/doi.org\/10.1002\/adma.202300692. Epub 2023\/04\/27.","journal-title":"Adv Mater"},{"issue":"6444","key":"2185_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.aaw7894","volume":"364","author":"SE Park","year":"2019","unstructured":"Park SE, Georgescu A, Huh D. Organoids-on-a-chip. Science. 2019;364(6444):960\u20135. https:\/\/doi.org\/10.1126\/science.aaw7894. Epub 2019\/06\/07.","journal-title":"Science"},{"issue":"4","key":"2185_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tibtech.2023.10.001","volume":"42","author":"M Jouybar","year":"2024","unstructured":"Jouybar M, de Winde CM, Wolf K, Friedl P, Mebius RE, den Toonder JMJ. Cancer-on-chip models for metastasis: importance of the tumor microenvironment. Trends Biotechnol. 2024;42(4):431\u201348. https:\/\/doi.org\/10.1016\/j.tibtech.2023.10.001. Epub 2023\/11\/02.","journal-title":"Trends Biotechnol"},{"issue":"21","key":"2185_CR18","doi-asserted-by":"publisher","first-page":"e2302436","DOI":"10.1002\/adhm.202302436","volume":"13","author":"A Brooks","year":"2024","unstructured":"Brooks A, Zhang Y, Chen J, Zhao CX. Cancer Metastasis-on-a-Chip for Modeling Metastatic Cascade and Drug Screening. Adv Healthc Mater. 2024;13(21):e2302436. https:\/\/doi.org\/10.1002\/adhm.202302436. Epub 20240126.","journal-title":"Adv Healthc Mater"},{"issue":"17","key":"2185_CR19","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1158\/0008-5472.CAN-14-1042","volume":"74","author":"AD Wong","year":"2014","unstructured":"Wong AD, Searson PC. Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer Res. 2014;74(17):4937\u201345. Epub 20140626. doi: 10.1158\/0008-5472.Can-14-1042. PubMed PMID: 24970480; PubMed Central PMCID: PMC4155070.","journal-title":"Cancer Res"},{"issue":"22","key":"2185_CR20","doi-asserted-by":"publisher","first-page":"6453","DOI":"10.1158\/0008-5472.CAN-16-3279","volume":"77","author":"AD Wong","year":"2017","unstructured":"Wong AD, Searson PC. Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor-Microvessel Platform. Cancer Res. 2017;77(22):6453\u201361. Epub 20170918. doi: 10.1158\/0008-5472.Can-16-3279. PubMed PMID: 28923855; PubMed Central PMCID: PMC5690825.","journal-title":"Cancer Res"},{"issue":"7","key":"2185_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3779\/j.issn.1009","volume":"13","author":"P Li","year":"2010","unstructured":"Li P, Wang Q, Wang H, Ma Z. [Research progresses of albumin-bound paclitaxel in the treatment of non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2010;13(7):748\u201352. https:\/\/doi.org\/10.3779\/j.issn.1009. Epub 2010\/08\/03.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"21","key":"2185_CR22","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/jco.2007.15","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008;26(21):3543\u201351. https:\/\/doi.org\/10.1200\/jco.2007.15. Epub 2008\/05\/29.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2185_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3779\/j.issn.1009-3419.2021.103","volume":"24","author":"H Xing","year":"2021","unstructured":"Xing H, Zhang J, Ge F, Yu X, Bian H, Zhang F, et al. [Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2021;24(3):167\u201372. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2021.103. Epub 2021\/04\/06.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"4","key":"2185_CR24","first-page":"1055","volume":"12","author":"A Sevinc","year":"2011","unstructured":"Sevinc A, Kalender ME, Altinbas M, Ozkan M, Dikilitas M, Camci C. Irinotecan as a second-line monotherapy for small cell lung cancer. Asian Pac J Cancer Prev. 2011;12(4):1055\u20139. Epub 2011\/07\/28. PubMed PMID: 21790251.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"2185_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1023\/a:1008213732429","volume":"9","author":"E Raymond","year":"1998","unstructured":"Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol. 1998;9(10):1053\u201371. https:\/\/doi.org\/10.1023\/a:1008213732429. Epub 1998\/12\/03.","journal-title":"Ann Oncol"},{"issue":"2","key":"2185_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0169-5002(99)00098-7","volume":"27","author":"S Ricci","year":"2000","unstructured":"Ricci S, Antonuzzo A, Galli L, Tibaldi C, Bertuccelli M, Lopes Pegna A, et al. Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study. Lung Cancer. 2000;27(2):75\u201380. https:\/\/doi.org\/10.1016\/s0169-5002(99)00098-7. Epub 2000\/02\/25.","journal-title":"Lung Cancer"},{"key":"2185_CR27","doi-asserted-by":"publisher","unstructured":"Niu X, Wu T, Yin Q, Gu X, Li G, Zhou C et al. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer. Cells. 2022;11(19). Epub 20221001. https:\/\/doi.org\/10.3390\/cells11193094. PubMed PMID: 36231056; PubMed Central PMCID: PMC9563422.","DOI":"10.3390\/cells11193094"},{"key":"2185_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364\u201378. Epub 20140721. doi: 10.1016\/j.ejphar.2014.07.025. PubMed PMID: 25058905; PubMed Central PMCID: PMC4146684.","journal-title":"Eur J Pharmacol"},{"key":"2185_CR29","doi-asserted-by":"publisher","unstructured":"Kciuk M, Marciniak B, Kontek R. Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview. Int J Mol Sci. 2020;21(14). Epub 20200712. https:\/\/doi.org\/10.3390\/ijms21144919. PubMed PMID: 32664667; PubMed Central PMCID: PMC7404108.","DOI":"10.3390\/ijms21144919"},{"issue":"36","key":"2185_CR30","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1200\/jco.23.01895","volume":"41","author":"EM O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly EM, Ko AH, Friedberg JW. Flashback Foreword: Gemcitabine for Advanced Pancreatic Cancer. J Clin Oncol. 2023;41(36):5479\u201380. https:\/\/doi.org\/10.1200\/jco.23.01895 . PubMed PMID: 38100990; PubMed Central PMCID: PMC10730035.","journal-title":"J Clin Oncol"},{"key":"2185_CR31","doi-asserted-by":"publisher","unstructured":"Abu Samaan TM, Samec M, Liskova A, Kubatka P, B\u00fcsselberg D. Paclitaxel\u2019s Mechanistic and Clinical Effects on Breast Cancer. Biomolecules. 2019;9(12). Epub 20191127. https:\/\/doi.org\/10.3390\/biom9120789. PubMed PMID: 31783552; PubMed Central PMCID: PMC6995578.","DOI":"10.3390\/biom9120789"},{"issue":"1","key":"2185_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0169-5002","volume":"41","author":"V Franciosi","year":"2003","unstructured":"Franciosi V, Barbieri R, Aitini E, Vasini G, Cacciani GC, Capra R, et al. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients. Lung Cancer. 2003;41(1):101\u20136. https:\/\/doi.org\/10.1016\/s0169-5002. (03)00150-8. PubMed PMID: 12826318.","journal-title":"Lung Cancer"},{"key":"2185_CR33","doi-asserted-by":"publisher","unstructured":"Brewster DJ. Ethanol preference in strains of rats selectively bred for behavioral characteristics. Ann N Y Acad Sci. 1972;197:49\u201353. https:\/\/doi.org\/10.1111\/j.1749-6632.1972.tb28117.x. PubMed PMID: 4504603.","DOI":"10.1111\/j.1749-6632.1972.tb28117.x"},{"issue":"2","key":"2185_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7150\/ijbs.65019","volume":"18","author":"X Yan","year":"2022","unstructured":"Yan X, Yao C, Fang C, Han M, Gong C, Hu D, et al. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022;18(2):585\u201398. https:\/\/doi.org\/10.7150\/ijbs.65019. Epub 2022\/01\/11.","journal-title":"Int J Biol Sci"},{"issue":"33","key":"2185_CR35","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1038\/onc.2017.93","volume":"36","author":"H Yurugi","year":"2017","unstructured":"Yurugi H, Marini F, Weber C, David K, Zhao Q, Binder H, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017;36(33):4778\u201389. https:\/\/doi.org\/10.1038\/onc.2017.93. Epub 2017\/04\/18.","journal-title":"Oncogene"},{"issue":"4","key":"2185_CR36","doi-asserted-by":"publisher","first-page":"1800726","DOI":"10.1002\/admt.201800726","volume":"4","author":"Z Guo","year":"2019","unstructured":"Guo Z, Yang C-T, Maritz MF, Wu H, Wilson P, Warkiani ME, et al. Validation of a Vasculogenesis Microfluidic Model for Radiobiological Studies of the Human Microvasculature. Adv Mater Technol. 2019;4(4):1800726. https:\/\/doi.org\/10.1002\/admt.201800726.","journal-title":"Adv Mater Technol"},{"issue":"35","key":"2185_CR37","doi-asserted-by":"publisher","first-page":"2204395","DOI":"10.1002\/advs.202204395","volume":"9","author":"Z Guo","year":"2022","unstructured":"Guo Z, Zhao N, Chung TD, Singh A, Pandey I, Wang L, et al. Visualization of the Dynamics of Invasion and Intravasation of the Bacterium That Causes Lyme Disease in a Tissue Engineered Dermal Microvessel Model. Adv Sci. 2022;9(35):2204395. https:\/\/doi.org\/10.1002\/advs.202204395.","journal-title":"Adv Sci"},{"issue":"8","key":"2185_CR38","doi-asserted-by":"publisher","first-page":"2200471","DOI":"10.1002\/smtd.202200471","volume":"6","author":"Z Guo","year":"2022","unstructured":"Guo Z, Yang C-T, Chien C-C, Selth LA, Bagnaninchi PO, Thierry B. Optical Cellular Micromotion: A New Paradigm to Measure Tumor Cells Invasion within Gels Mimicking the 3D Tumor Environments. Small Methods. 2022;6(8):2200471. https:\/\/doi.org\/10.1002\/smtd.202200471.","journal-title":"Small Methods"},{"key":"2185_CR39","doi-asserted-by":"publisher","unstructured":"Wang X, Zhu G, Lu J, Hu X, Zheng W, Yang K et al. A Vascularized Lung Tumoroid-on-Chip Model for the Accurate Assessment of Anti-Invasion Agents. Advanced Functional Materials.n\/a(n\/a):e26981. https:\/\/doi.org\/10.1002\/adfm.202526981","DOI":"10.1002\/adfm.202526981"},{"issue":"9","key":"2185_CR40","doi-asserted-by":"publisher","first-page":"e11169","DOI":"10.1002\/advs.202511169","volume":"13","author":"K Yang","year":"2026","unstructured":"Yang K, Chu X, Wang X, Zhang W, Lu J, Xu C, et al. Novel Vascularized Human Liver Organoids for Modeling Alcohol-Induced Liver Injury and Developing Hepatoprotective Therapy. Adv Sci. 2026;13(9):e11169. https:\/\/doi.org\/10.1002\/advs.202511169.","journal-title":"Adv Sci"},{"issue":"6","key":"2185_CR41","doi-asserted-by":"publisher","first-page":"e2412815","DOI":"10.1002\/adma.202412815","volume":"37","author":"Y Du","year":"2025","unstructured":"Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, et al. Personalized Vascularized Tumor Organoid-on-a-Chip for Tumor Metastasis and Therapeutic Targeting Assessment. Adv Mater. 2025;37(6):e2412815. https:\/\/doi.org\/10.1002\/adma.202412815. Epub 20241226.","journal-title":"Adv Mater"},{"issue":"1","key":"2185_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12987-023-00482-9","volume":"20","author":"RM Linville","year":"2023","unstructured":"Linville RM, Maressa J, Guo Z, Chung TD, Farrell A, Jha R, et al. A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer. Fluids Barriers CNS. 2023;20(1):80. https:\/\/doi.org\/10.1186\/s12987-023-00482-9. Epub 2023\/11\/04 21:42.","journal-title":"Fluids Barriers CNS"},{"key":"2185_CR43","doi-asserted-by":"publisher","unstructured":"Shirure VS, Hughes CCW, George SC. Engineering Vascularized Organoid-on-a-Chip Models. Annu Rev Biomed Eng. 2021;23:141\u2009\u2013\u200967. Epub 2021\/03\/24. https:\/\/doi.org\/10.1146\/annurev-bioeng-090120-094330. PubMed PMID: 33756087.","DOI":"10.1146\/annurev-bioeng-090120-094330"},{"issue":"19","key":"2185_CR44","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1158\/0008-5472.Can-19-1564","volume":"80","author":"VL Silvestri","year":"2020","unstructured":"Silvestri VL, Henriet E, Linville RM, Wong AD, Searson PC, Ewald AJ. A Tissue-Engineered 3D Microvessel Model Reveals the Dynamics of Mosaic Vessel Formation in Breast Cancer. Cancer Res. 2020;80(19):4288\u2013301. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-1564. Epub 20200714.","journal-title":"Cancer Res"},{"issue":"1","key":"2185_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.12336\/biomatertransl.2024.01.003","volume":"5","author":"Z Li","year":"2024","unstructured":"Li Z, Yu D, Zhou C, Wang F, Lu K, Liu Y, et al. Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives. Biomater Transl. 2024;5(1):21\u201332. https:\/\/doi.org\/10.12336\/biomatertransl.2024.01.003. Epub 2024\/09\/02.","journal-title":"Biomater Transl"},{"key":"2185_CR46","doi-asserted-by":"publisher","first-page":"114365","DOI":"10.1016\/j.addr.2022.114365","volume":"187","author":"J Zhang","year":"2022","unstructured":"Zhang J, Tavakoli H, Ma L, Li X, Han L, Li X. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment. Adv Drug Deliv Rev. 2022;187:114365. https:\/\/doi.org\/10.1016\/j.addr.2022.114365. Epub 2022\/06\/07.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2185_CR47","doi-asserted-by":"publisher","first-page":"35099","DOI":"10.1038\/srep35099","volume":"6","author":"LR Cisneros Castillo","year":"2016","unstructured":"Cisneros Castillo LR, Oancea A-D, St\u00fcllein C, R\u00e9gnier-Vigouroux A. A Novel Computer-Assisted Approach to evaluate Multicellular Tumor Spheroid Invasion Assay. Sci Rep. 2016;6(1):35099. https:\/\/doi.org\/10.1038\/srep35099.","journal-title":"Sci Rep"},{"issue":"3","key":"2185_CR48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/acsmeasuresciau.3c00064","volume":"4","author":"J Heiss","year":"2024","unstructured":"Heiss J, Tavana H. Automated Analysis of Extracellular Matrix Invasion of Cancer Cells from Tumor Spheroids. ACS Meas Sci Au. 2024;4(3):260\u20136. https:\/\/doi.org\/10.1021\/acsmeasuresciau.3c00064. Epub 20231228.","journal-title":"ACS Meas Sci Au"},{"issue":"4","key":"2185_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jrr\/rru002","volume":"55","author":"K Murata","year":"2014","unstructured":"Murata K, Noda SE, Oike T, Takahashi A, Yoshida Y, Suzuki Y, et al. Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells. J Radiat Res. 2014;55(4):658\u201364. https:\/\/doi.org\/10.1093\/jrr\/rru002. Epub 2014\/03\/25.","journal-title":"J Radiat Res"},{"key":"2185_CR50","doi-asserted-by":"publisher","unstructured":"Yoh HZ, Chen Y, Shokouhi AR, Thissen H, Voelcker NH, Elnathan R. The influence of dysfunctional actin on polystyrene-nanotube-mediated mRNA nanoinjection into mammalian cells. Nanoscale. 2023;15(17):7737-44. Epub 2023\/04\/18. https:\/\/doi.org\/10.1039\/d3nr01111a. PubMed PMID: 37066984.","DOI":"10.1039\/d3nr01111a"},{"issue":"3","key":"2185_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3748\/wjg.v29.i3.579","volume":"29","author":"JH Huang","year":"2023","unstructured":"Huang JH, Guo W, Liu Z. Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer. World J Gastroenterol. 2023;29(3):579\u201381. https:\/\/doi.org\/10.3748\/wjg.v29.i3.579 . PubMed PMID: 36688025; PubMed Central PMCID: PMC9850937.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2185_CR52","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2174\/092986712799320682","volume":"19","author":"DS Gesto","year":"2012","unstructured":"Gesto DS, Cerqueira NM, Fernandes PA, Ramos MJ. Gemcitabine: a critical nucleoside for cancer therapy. Curr Med Chem. 2012;19(7):1076\u201387. 10.2174\/092986712799320682. PubMed PMID: 22257063.","journal-title":"Curr Med Chem"},{"key":"2185_CR53","doi-asserted-by":"publisher","first-page":"216382","DOI":"10.1016\/j.canlet.2023.216382","volume":"573","author":"J Natu","year":"2023","unstructured":"Natu J, Nagaraju GP. Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies. Cancer Lett. 2023;573:216382. https:\/\/doi.org\/10.1016\/j.canlet.2023.216382. Epub 20230902.","journal-title":"Cancer Lett"},{"key":"2185_CR54","doi-asserted-by":"publisher","first-page":"110170","DOI":"10.1016\/j.cbi.2022.110170","volume":"368","author":"MR Islam","year":"2022","unstructured":"Islam MR, Akash S, Rahman MM, Nowrin FT, Akter T, Shohag S, et al. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. Chem Biol Interact. 2022;368:110170. https:\/\/doi.org\/10.1016\/j.cbi.2022.110170. Epub 2022\/10\/07.","journal-title":"Chem Biol Interact"},{"key":"2185_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.04","author":"J Ying","year":"2018","unstructured":"Ying J, Zhang M, Qiu X, Lu Y. The potential of herb medicines in the treatment of esophageal cancer. Biomed Pharmacother. 2018;103. https:\/\/doi.org\/10.1016\/j.biopha.2018.04. Epub 2018\/04\/21. :381\u2009\u2013\u200990."},{"issue":"10","key":"2185_CR56","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1080\/15548627.2018.1489946","volume":"14","author":"C Yao","year":"2018","unstructured":"Yao C, Ni Z, Gong C, Zhu X, Wang L, Xu Z, et al. Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy. Autophagy. 2018;14(10):1831\u201344. PubMed PMID: 29969944; PubMed Central PMCID: PMC6135631.","journal-title":"Autophagy"},{"issue":"47","key":"2185_CR57","doi-asserted-by":"publisher","first-page":"44791","DOI":"10.1074\/jbc.M208003200","volume":"277","author":"B Baumann","year":"2002","unstructured":"Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, et al. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem. 2002;277(47):44791\u2013800. https:\/\/doi.org\/10.1074\/jbc.M208003200. Epub 2002\/09\/19.","journal-title":"J Biol Chem"},{"issue":"29","key":"2185_CR58","doi-asserted-by":"publisher","first-page":"e2202093","DOI":"10.1002\/advs.202202093","volume":"9","author":"WW Cho","year":"2022","unstructured":"Cho WW, Ahn M, Kim BS, Cho DW. Blood-Lymphatic Integrated System with Heterogeneous Melanoma Spheroids via In-Bath Three-Dimensional Bioprinting for Modelling of Combinational Targeted Therapy. Adv Sci (Weinh). 2022;9(29):e2202093. https:\/\/doi.org\/10.1002\/advs.202202093. Epub 20220826.","journal-title":"Adv Sci (Weinh)"},{"issue":"14","key":"2185_CR59","doi-asserted-by":"publisher","first-page":"e1806590","DOI":"10.1002\/adma.201806590","volume":"31","author":"MA Heinrich","year":"2019","unstructured":"Heinrich MA, Bansal R, Lammers T, Zhang YS, Michel Schiffelers R, Prakash J. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics. Adv Mater. 2019;31(14):e1806590. https:\/\/doi.org\/10.1002\/adma.201806590. Epub 20190131.","journal-title":"Adv Mater"},{"key":"2185_CR60","doi-asserted-by":"publisher","unstructured":"J Lu, Y Huang, S Hu, L Xuzhan, Y Huang, B Wu, et. al. Modeling Metastasis with Tumor Organoid-on-a-Chip: from Mechanistic Study to Anti-Tumor Drug Discovery, TrAC Trends in Analytical Chemistry. 2026; 199: 118197. https:\/\/doi.org\/10.1016\/j.trac.2026.118791","DOI":"10.1016\/j.trac.2026.118791"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02185-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:02:01Z","timestamp":1783954921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02185-5","relation":{"references":[{"id-type":"doi","id":"10.1038\/nprot.2017.018","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.biopha.2018.04","asserted-by":"subject"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to participate, and consent to publish declarations"}}],"article-number":"266"}}